Prevalence of the fragile x syndrome in African-Americans

被引:97
作者
Crawford, DC
Meadows, KL
Newman, JL
Taft, LF
Scott, E
Leslie, M
Shubek, L
Holmgreen, P
Yeargin-Allsopp, M
Boyle, C
Sherman, SL
机构
[1] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 110卷 / 03期
关键词
fragile x syndrome; FRAXA; CGG; African-American; FMR1; prevalence;
D O I
10.1002/ajmg.10427
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Since the development of a molecular diagnosis for the fragile X syndrome in the early 1990s, several population-based studies in Caucasians of mostly northern European descent have established that the prevalence is probably between one in 6,000 to one in 4,000 males in the general population. Reports of increased or decreased prevalence of the fragile X syndrome exist for a few other world populations; however, many of these are small and not population-based. We present here the final results of a 4-year study in the metropolitan area of Atlanta, Georgia, establishing the prevalence of the fragile X syndrome and the frequency of CGG repeat variants in a large Caucasian and African-American population. Results demonstrate that one-quarter to one-third of the children identified with the fragile X syndrome attending Atlanta public schools are not diagnosed before the age of 10 years. Also, a revised prevalence for the syndrome revealed a higher point estimate for African-American males (1/2,545; 95% CI: 1/5,208-1/1,289) than reported previously, although confidence intervals include the prevalence estimated for Caucasians from this (1/3,717; 95% CI: 1/7,692-1/1,869) and other studies. Further population-based studies in diverse populations are necessary to explore the possibility that the prevalence of the fragile X syndrome differs among world populations. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:226 / 233
页数:8
相关论文
共 52 条
  • [41] 2-I
  • [42] Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397
  • [43] Syrrou M, 1998, GENET EPIDEMIOL, V15, P103, DOI 10.1002/(SICI)1098-2272(1998)15:1<103::AID-GEPI8>3.3.CO
  • [44] 2-L
  • [45] Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.3.CO
  • [46] 2-W
  • [47] Elevated levels of FMR1 mRNA in carrier males:: A new mechanism of involvement in the fragile-X syndrome
    Tassone, F
    Hagerman, RJ
    Taylor, AK
    Gane, LW
    Godfrey, TE
    Hagerman, PJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (01) : 6 - 15
  • [48] Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel
    Toledano-Alhadef, H
    Basel-Vanagaite, L
    Magal, N
    Davidov, B
    Ehrlich, S
    Drasinover, V
    Taub, E
    Halpern, GJ
    Ginott, N
    Shohat, M
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) : 351 - 360
  • [49] Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO
  • [50] 2-G